These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24015333)

  • 1. Chronic thromboembolic pulmonary hypertension: Medical treatment.
    Ozsu S; Cinarka H
    Pulm Circ; 2013 Apr; 3(2):341-4. PubMed ID: 24015333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension.
    Pepke-Zaba J; Jais X; Channick R
    Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S248-54. PubMed ID: 27571006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
    Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z
    Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic thromboembolic pulmonary hypertension: role of medical therapy.
    Pepke-Zaba J; Jansa P; Kim NH; Naeije R; Simonneau G
    Eur Respir J; 2013 Apr; 41(4):985-90. PubMed ID: 23397304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in pulmonary arterial hypertension-targeted therapy for chronic thromboembolic pulmonary hypertension.
    Hadinnapola C; Pepke-Zaba J
    Expert Rev Respir Med; 2015 Oct; 9(5):559-69. PubMed ID: 26366805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
    Garnock-Jones KP
    Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
    Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
    J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
    Pepke-Zaba J; Delcroix M; Lang I; Mayer E; Jansa P; Ambroz D; Treacy C; D'Armini AM; Morsolini M; Snijder R; Bresser P; Torbicki A; Kristensen B; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Hamid AM; Jaïs X; Simonneau G
    Circulation; 2011 Nov; 124(18):1973-81. PubMed ID: 21969018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic thromboembolic pulmonary hypertension.
    Hoeper MM; Madani MM; Nakanishi N; Meyer B; Cebotari S; Rubin LJ
    Lancet Respir Med; 2014 Jul; 2(7):573-82. PubMed ID: 24898750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.
    Bresser P; Pepke-Zaba J; Jaïs X; Humbert M; Hoeper MM
    Proc Am Thorac Soc; 2006 Sep; 3(7):594-600. PubMed ID: 16963540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat].
    Gratsianskaya SE; Valieva ZS; Martynyuk TV
    Ter Arkh; 2020 Oct; 92(9):77-84. PubMed ID: 33346435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Hypertension: A Brief Guide for Clinicians.
    Mandras SA; Mehta HS; Vaidya A
    Mayo Clin Proc; 2020 Sep; 95(9):1978-1988. PubMed ID: 32861339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.
    Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T
    Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension.
    Ghofrani HA; D'Armini AM; Kim NH; Mayer E; Simonneau G
    Respir Med; 2021 Feb; 177():106293. PubMed ID: 33465538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan for chronic thromboembolic pulmonary hypertension.
    Confalonieri M; Kodric M; Longo C; Vassallo FG
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic thromboembolic pulmonary hypertension: evolution in management.
    LeVarge BL; Channick RN
    Curr Opin Pulm Med; 2014 Sep; 20(5):400-8. PubMed ID: 25093673
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.